Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data

BACKGROUND: Methylphenidate (MPH) is commonly prescribed in the treatment of Attention-Deficit/Hyperactivity Disorder or ADHD. Concerta and Metadate CD are once-daily formulations of MPH using different delivery mechanisms resulting in different pharmacokinetic profiles. A recent study (COMACS) show...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonuga-Barke, Edmund JS, Swanson, James M, Coghill, David, DeCory, Heleen H, Hatch, Simon J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524494/
https://www.ncbi.nlm.nih.gov/pubmed/15458569
http://dx.doi.org/10.1186/1471-244X-4-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524494/
https://www.ncbi.nlm.nih.gov/pubmed/15458569
http://dx.doi.org/10.1186/1471-244X-4-28

Ejemplares similares